Abstract. We have isolated Swiss 3T3 subclones that are resistant to the rnitogenic and morphological transforming effects of v-Src as a consequence of aberrant translocation of the oncoprotein under low serum conditions. In chicken embryo and NIH 3T3 fibroblasts under similar conditions, v-Src rapidly translocates from the perinuclear region to the focal adhesions upon activation of the tyrosine kinase, resulting in downstream activation of activator protein-1 and mitogen-activated protein kinase, which are required for the mitogenic and transforming activity of the oncoprotein. Since serum deprivation induces cytoskeletal disorganization in Swiss 3T3, we examined whether regulators of the cytoskeleton play a role in the translocation of v-Src, and also c-Src, in response to biological stimuli. Actin stress fibers and translocation of active v-Src to focal adhesions in quiescent Swiss 3T3 cells were restored by microinjection of activated Rho A and by serum. Double labeling with anti-Src and phalloidin demonstrated that v-Src localized along the reformed actin filaments in a pattern that would be consistent with trafficking in complexes along the stress fibers to focal adhesions. Furthermore, treatment with the actin-disrupting drug cytochalasin D, but not the microtubule-disrupting drug nocodazole, prevented v-Src translocation. In addition to v-Src, we observed that PDGF-induced, Racmediated membrane ruffling was accompanied by translocation of c-Src from the cytoplasm to the plasma membrane, an effect that was also blocked by cytochalasin D. Thus, we conclude that translocation of Src from its site of synthesis to its site of action at the cell membrane requires an intact cytoskeletal network and that the small G proteins of the Rho family may specify the peripheral localization in focal adhesions or along the membrane, mediated by their effects on the cytoskeleton.
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T
HE product of the v-src gene is a protein tyrosine kinase that, in its active form, localizes to the plasma membrane where it initiates a cascade of signaling events leading to altered cell growth and behavior. We, and others, have extensively studied the GdG1-to S-phase progression induced by v-Src in rat and chicken embryo cells withdrawn from the cell cycle by serum deprivation (Bell et al., 1975; Durkin and Whitfield, 1984; Welham et al., 1990; Catling et al., 1993; Wyke et al., 1993) . Over the past few years, some of the intracellular signals that are crucial for the mitogenic activity of the v-Src oncoprotein have been identified. These include the signaling pathway that links p21 Ras to the mitogen-activated protein (MAP) 1 ki-nases and their targets (Gupta et al., 1992; Howe et al., 1992; Wang and Erickson, 1992; Cowley et al., 1994; Wyke et al., 1995) and the transcription factor AP-1, which is activated by a variety of mechanisms in different cell types (Welham et al., 1990; Catling et al., 1993) . In addition, we have demonstrated that activation of MAP kinase and activator protein-1 (AP-1) occur at times during G1 when v-Src activity is required and that both are necessary for mitogenesis Wyke et al., 1995) . We have also shown that the ability of v-Src to morphologically transform fibroblasts is not impaired by attenuation of either MAP kinase or AP-1 activation, indicating that the pathways that regulate mitogenesis are biochemically distinct from those that induce cell shape changes Wyke et al., 1995) . However, both the mitogenic and morphological effects of v-Src require its localization at the cell membrane (Catling et al., 1993) .
Despite our increasing understanding of the role of the Ras/MAP kinase pathway and AP-1 in the mitogenic activity of v-Src, there is still no clear information on the upstream events that initiate this process. Our studies to date have used Rat-1 or chicken embryo fibroblasts expressing a temperature-sensitive mutant of v-Src (ts LA29), in which a single point mutation in the kinase domain gives rise to both temperature-dependent kinase activity and temperature-dependent localization to the cell periphery (Welham and Wyke, 1988) . In this study, we describe Swiss 3T3 cell clones that are resistant to the mitogenic effects of ts LA29 v-Src upon shifting serum-deprived cells to the permissive temperature and describe characterization of the defect that is responsible for the lack of v-Srcinduced MAP kinase and AP-1 activation and their biological consequences. For comparison, we used ts LA29 v-Src-expressing NIH 3T3 cells that undergo G 0-to S-phase transition in response to shift to permissive temperature. We demonstrate that cytoskeletal disruption, which occurs in Swiss 3T3 cells that have been deprived of serum (RidIcy and Hall, 1992) , is associated with their resistance to v-Src-induced mitogenesis as a consequence of impaired translocation of ts LA29 v-Src to the cell periphery. We further show that serum-induced reformation of the organized actin cytoskeletal network restores v-Src translocation upon shift to permissive temperature. These observations led us also to examine the subcellular localization of c-Src in response to a biological stimulus known to require c-Src activity and to conclude that the cytoskeleton also plays a crucial role in the redistribution of c-Src from the perinuclear cytoplasm to its membrane sites of action. We provide evidence that stimulus-specific cytoskeletal rearrangements, which are known to be mediated by members of the Rho family of small G proteins, may specify the localization of Src kinases at the plasma membrane.
Materials and Methods

Generation of Cell Lines
Swiss 3T3 and NIH 3T3 cell lines grown in DME supplemented with 10% FCS were transfected with 1 ~g of the Moloney murine leukaemia virus based vector fpGV-1 (DeClue and Martin, 1989) , into which the coding sequences for ts LA29 v-src had been cloned (provided to us by Andy Catling, The Beatson Institute). Transfections were by the DOTAP method (Boehringer Mannheim Corp., Indianapolis, IN) as per manufacturer's instructions, and neomycin-resistant colonies were selected in G418 (GIBCO BRL) at 500 ixg/ml. Single colonies were isolated and those shown to express high levels of v-Src by immunoblotting (see Fig.  1 ) were chosen for study. CEF/R29 used for comparison in v-Src localization studies were generated by transfection of the replication competent Rous-associated virus encoding ts LA29 v-src as described previously (Catling et al., 1994) . Cytochalasin D (Sigma Chemical Co., St. Louis, MO) was dissolved in DMSO and added to the culture medium to a final concentration of 0.1 p.g/ml. Nocodazole (Sigma Chemical Co.) was dissolved in DMSO and used at 0.5 ixg/ml.
Immunoblotting and Src Kinase Assays
v-Src was detected by preparing lysates in 0.1 M Tris, pH 8, 2% SDS and 1 mM DTT, which were separated on a 10% SDS-PAGE, blotted onto nitrocellulose, blocked with 5% milk, and probed with mAb ECIO (Upstate Biotechnology, Inc., Lake Placid, NY) specific for avian Src. Detection was by reaction with sheep anti-mouse IgG conjugated to horseradish peroxidase and ECL (Amersham Corp., Arlington Heights, IL). Immune-complex kinase assays were carried out as follows. Cultures were lysed in NP-40 buffer (20 mM Tris, pH 6.8, 150 mM sodium chloride, 1% NP-40, 20 mM sodium pyrophosphate, 10 i.tM sodium orthovanadate, 2 I.LM PMSF, 1 p~g/ml aprotinin) for 20 min on ice. Lysates were clarified by high-speed spin at 4°C and precleared with normal rabbit serum and protein A-Sepharose (Sigma Chemical Co.). v-Src from 50 Izg lysate was reacted with mAb EC10 (Upstate Biotechnology, Inc.) and collected on rabbit anti-mouse-coated protein A-Sepharose. Immunoprecipitates were washed in NP-40 buffer and kinase assay buffer (1130 mM Pipes-sodium, pH 6.8, 20 mM manganese chloride, 10 p.M sodium orthovanadate) before resuspending in kinase assay buffer. An aliquot of v-Src-protein A--Sepharose (amount checked so that assay conditions were linear) was incubated with 5 p.Ci of [~-32p]ATP (3,000 Ci/mM) (Amersham Corp.) and 1 ~g denatured enolase in a final assay volume of 20 I~1. The reaction was stopped by addition of 20 p,l 0.1 M Tris, pH 8, 2% SDS, and 1 mM DTT, and the supernatant was separated by 10% SDS-PAGE. Lysate protein concentrations for immune-complex kinase assays and AP-1 DNA-binding assays were determined using the Micro BCA Protein Assay Kit (Pierce, Rockford, IL).
Mitogenesis
Cells were made quiescent by transferring to medium containing 0.4% newborn calf serum and maintained at the restrictive temperature (40°C) for 24--48 h. Stimulation was by shift to the permissive temperature (35°C) or addition of 10% serum. DNA synthesis was measured by pulse labeling with tritiated methylthymidine (Amersham Corp.) as described previously (Welham et al., 1990) .
AP-1 DNA--binding and MAP Kinase Assays
Cells from 100-mm dishes were lysed in 100 ~1 of buffer containing 20 mM Hepes, pH 7.9, 5 mM EDTA, 10 mM EGTA, 5 mM sodium fluoride, 0.1 p.g/ml okadaic acid, 1 mM DTT, 0.4 M potassium chloride, 0.4% Triton X-100, 10% glycerol, and a mixture of protease inhibitors including pepstatin A, leupeptin, and aprotinin (all at 5 p,g/ml), together with 1 mM benzamidine and 0.25 mM PMSF. Lysates were clarified by high-speed spin at 4°C. DNA-binding reactions were carried out in 20 mM Hepes buffer, pH 7.9, with 50 mM sodium chloride, 5 mM magnesium chloride, and 3 ~g poly-dldC. An oligonucleotide probe representing the collagenase AP-1 site (AGCTGTGTCTGACTCATGCT) was end labeled using [~/-32p]ATP and T4 polynucleotide kinase (Northumberland Biologicats) and incubated with 15 p,g protein for 30 min on ice. DNA-protein complexes were resolved by electrophoresis in 4% polyacrylamide gels.
The activity of p42 MAP kinase (ERK2) in 50 p.g cell lysate was measured by immune-complex kinase assays using an antiserum raised against the carboxy-terminal peptide of ERK2 as was used by Leevers and Marshall (1992) , exactly as described in Wyke et al. (1995) .
Immunofluorescence
For immunofluorescence confocal microscopy, cells were grown on glass coverslips, fixed at 4°C for 15 min with 3.7% formaldehyde, and permeabilized with 0.5% Triton X-100 before incubation with 1:1,000 anti-Src mAb EC10, 1:100 antivinculin (Sigma Chemical Co.), 1:5 anti-Src mAb N2-17 (gift from Tony Hunter, Salk Institute, San Diego, CA), 1:500 anfitubulin (Sigma Chemical Co.), or 1 ng/ml TRITC-conjugated phalloidin (Sigma Chemical Co.) for 60 min at room temperature. Antibody detection was by reaction with FITC-conjugated goat anti-mouse tgG (Sigma Chemical Co.) for 45 rain at room temperature. As control, cells were incubated with conjugated second antibody alone. The cells were visualized using a confocal microscope (model MRC600; BioRad Labs, Hercules, CA). Images were printed on a dye sublimation printer (Eastman Kodak, Rochester, NY).
Microinjection of Rho A
pGEX-2T-rho A was kindly provided to us by Alan Hall (University College, London, UK). We derived Val 14-rho A by PCR-based mutagenesis. GST-Val 14-Rho A protein was prepared, cleaved by thrombin (Sigma Chemical Co.) and purified as described for Rac proteins . Protein preparations were checked for activity by the method of Hall and Self (1986) . Val 14-Rho A protein (1 p.g/ml) in 50 mM Tris, pH 7.5, 50 mM NaC1, 5 mM Mg C12, and 0.01 mM DTT was mixed with filtered Lucifer yellow CH dye (2%) and injected into about 40 quiescent Swiss 3T3-f29 cells per experiment using a microiujector system (model 5254; Eppendorf, Inc., Fremont, CA). After microinjection, cells were incubated in low serum medium at 40°C for several hours before switching to 35°C. Swiss 3T3-f29 cells are not coupled by GAP junctions, and Lucifer yellow provided a marker of injected cells. As controls, we examined cells microinjected with dye alone and cells microinjected with Val 14-Rho A maintained at the restrictive temperature.
Results
Swiss 3T3 Cells A r e Resistant to v-Src-induced Mitogenesis
Initial characterization of several independent clones of Swiss 3T3, which stably express high levels of ts LA29 v-Src, demonstrated that the oncoprotein was unable to induce a mitogenic response in Swiss 3T3 cells that had been made quiescent by serum deprivation. This was shown by the lack of stimulation of thymidine uptake after shift to the permissive temperature (35°C) (Fig. 1 a) and was in contrast to fibroblasts from other species, including rat and chicken (Welham et al., 1990; Catling et al., 1993) . v-Src was also able to act as a mitogen in quiescent N I H 3T3 cells expressing similar amounts of ts LA29 v-Src ( Fig. 1 b) ,
showing that the lack of response in Swiss 3T3 was not a general property of mouse fibroblasts. Furthermore, addition of 10% serum induced reentry of quiescent Swiss 3T3 into cell cycle (Fig. 1 a) , indicating that these cells were able to respond mitogenically to an appropriate stimulus. 
AP-1 and M A P Kinase Are Not Activated by v-Src in Quiescent Swiss 3T3 Cells
Since we had previously shown that AP-1 and MAP kinase activation are essential components of v-Src-induced mitogenesis, we examined whether these were activated in serum-deprived Swiss 3T3-f29 and NIH 3T3-f29 after addition of serum or shift to 35°C. Although serum induced AP-1 DNA-binding activity, as measured by gel retardation of an AP-1 consensus oligonucleotide, shift to the permissive temperature did not appreciably induce AP-1 DNA binding in Swiss 3T3 (Fig. 2 a, top) . In contrast, activation of ts LA29 v-Src by shift to 35°C in N I H 3T3 cells resulted in an obvious stimulation of AP-1 D N A binding (Fig. 2 a, lower). Similarly, measurement of MAP kinase activity, using an immune-complex kinase assay with antiserum specific for the carboxy terminus of p42 MAP kinase and myelin basic protein (MBP) as substrate, demonstrated that shift to permissive temperature resulted in a classical early and transient activation in N I H 3T3-f29 (Fig. 2 b, right) but induced no response in Swiss 3T3-f29 (Fig. 2 b,  left) . These data show that AP-1 and MAP kinase are stimulated upon shift to 35°C in v-Src-responsive quiescent NIH 3T3 cells, but not in the v-Src-unresponsive Swiss 3T3 clones.
v-Src Is Not Translocated to the Cell Periphery in Quiescent Swiss 3T3 Cells
Since the defect in quiescent Swiss 3T3-f29 that renders the cells nonpermissive for v-Src-induced mitogenesis was apparently upstream of activation of MAP kinase, one possibility was that v-Src was not activated or localized properly upon shift to 35°C. One prediction of the hypothesis that the defect is aberrant regulation of v-Src itself is that shift of serum-deprived Swiss 3T3-f29 to 35°C would also not induce morphological transformation. Thus, we compared the cellular morphologies of Swiss 3T3-f29 and NIH 3T3-f29 that were either growing or serum deprived at the restrictive temperature (40°C) or after shift for 36 h to 35°C. As shown, serum-deprived Swiss 3T3-f29 cells shifted to 35°C (Fig. 3 a, lower) do not assume the refractile rounded morphology characteristic of growing cells transformed at 35°C, although they appear granular (Fig. 3 a, upper). In contrast, serum-deprived NIH 3T3-f29 become morphologically transformed at 35°C (Fig. 3 b) and appear similar to growing cells at this temperature (not shown). These observations confirm that the defect in v-Src activity in Swiss 3T3 cells is not confined to the mitogenic pathways, but that other biological consequences of v-Src activity are not induced when these cells are serum deprived. This is consistent with aberrant regulation of v-Src itself in serum-deprived Swiss 3T3 cells. Further characterization of Swiss 3T3-f29 clones showed that ts LA29 v-Src was able to induce not only morphological cell rounding when the cells were growing but also an enhanced growth rate and growth in soft agar in a temperature-dependent manner (data not shown), indicating that v-Src was able to function as an efficient oncoprotein in Swiss 3T3 cells grown in the presence of serum.
As mentioned, ts LA29 v-Src is both catalytically activated and relocalized from the perinuclear region to the cell membrane in response to shift to permissive tempera- ture in rat cells (Welham and Wyke, 1988 ). Thus, we tested the reactivation kinetics of the v-Src tyrosine kinase and its subcellular localization. The v-Src kinase from quiescent Swiss 3T3-f29 cells reactivated upon shift to 35°C with similar kinetics to v-Src from NIH 3T3-f29 cells, as demonstrated by immune-complex kinase assays using exogenous enolase as substrate (Fig. 4 a) . The level of v-Src protein was relatively invariant during temperature-shift of both cell lines, indicating that reactivation was due to increased specific kinase activity (Fig. 4 b) . Furthermore, the reactivation kinetics were similar to those for ts LA29 v-Src from quiescent chicken embryo fibroblasts (CEF/ R29), in which this v-Src mutant is an effective mitogen and transforming agent (Catling et al., 1993) . In addition, both quiescent Swiss 3T3-f29 and NIH 3T3-f29 exhibited temperature-dependent tyrosine phosphorylation of cellular proteins upon activation of v-Sre (not shown), demonstrating that activation of the tyrosine kinase occurs in vivo.
Examination of the subcellular distribution of v-Src showed that temperature-induced translocation to the cell periphery was impaired in serum-deprived Swiss 3T3-f29 (Fig. 5 a) . Immunofluorescence confocal microscopy using mAb EC10 demonstrated that in growing and serumdeprived Swiss 3T3-f29 at 40°C, v-Src was localized around the nucleus (Fig. 5 a, 1 and 3) . Control cells treated with conjugated second antibody alone displayed nuclear fluorescence that was not seen when primary antibody reactive with v-Src was also used (not shown). Upon shift to 35°C, a proportion of the v-Src localized to the cell periphery in growing cells, predominantly to discrete adhesions at early times (Fig. 5 a, 2, upper) , and to the membrane/residual adhesions at later times in rounded transformed cells in which v-Src had induced focal adhesion degradation (Fig. 5 a, 2, lower) . In contrast, v-Src remained mainly in the perinuclear region in cells, which had been deprived of serum, even after 4 h at the permissive temperature (Fig. 5 a, 4 and after shift to 35°C for 30 rain and 2 h, respectively. Bars, 20 p~m. remained perinuclear, although the serum-deprived Swiss 3T3-f29 cells became granular in appearance, indicating that the cells were unhealthy (Fig. 3 a) . For comparison, the normal translocation of ts LA29 v-Src to focal adhesions induced in CEF/R29 after shift to 35°C for 30 min (Fig. 5 b, 2) and in quiescent N I H 3T3-f29 after shift to 35°C for 2 h (Fig. 5 b, 4) responsive Swiss 3T3-f29 ceils is not translocated to its site of action in focal adhesions at the cell periphery upon shift to the permissive temperature.
Translocation of v-Src Requires an Organized Actin Cytoskeleton
Since Swiss 3T3 are known to differ from other fibroblasts by disorganizing the cellular stress fibers and focal adhesions upon serum deprivation (Ridley and Hall, 1992) , we examined the cytoskeleton of Swiss 3T3-f29 cells upon serum deprivation and after serum refeeding. As expected, phalloidin staining revealed that in serum-deprived Swiss 3T3-f29 cells, there were few stress fibers, with much of the actin having a punctate distribution (not shown); in contrast, stress fibers were detected in quiescent NIH 3T3-f29 (not shown). Upon refeeding Swiss 3T3-f29 cells with serum, new stress fibers formed rapidly, a process that is known to be dependent on the activity of the small G protein Rho (Ridley and Hall, 1992) . Thus, the loss of organized actin stress fibers in quiescent Swiss 3T3 f-29 cells correlated with the lack of v-Src translocation to the cell periphery. We then tested whether serum-induced reformation of actin stress fibers restored the ability of ts LA29 v-Src to translocate to the membrane. Addition of serum for 1 h at 35°C resulted in the redistribution of some v-Src from around the nucleus outwards to the cell periphery (Fig. 6 a) . The staining pattern indicated that v-Src was present in discrete structures or complexes that appeared to align with the newly formed actin stress fibers, shown in Fig. 6 b for the same cell. When the eonfocal images from staining with anti-v-Src (detected by FITC as green in Fig.  6 a) and phalloidin (detected by rhodamine as red in Fig. 6 b) were overlaid, the colocalization of the v-Src-containing complexes with the stress fibers became evident (detected as yellow) (Fig. 6 c) . This pattern was consistent with the idea that v-Src--containing complexes may track along the newly formed actin cables to focal adhesions at the stress fiber termini. Overlaid images of a group of cells after shift to permissive temperature for a longer period in the pres- ence of serum (4 h), showed that much of the v-Src was now localized in adhesions at the ends of stress fibers (Fig.  6 d) . The v-Src-containing complexes at these termini assumed a more elongated shape, reminiscent of mature focal adhesions in Swiss 3T3 cells (Barry and Critchley, 1994) . Microinjection of an activated form of the small G protein Rho A (Val 14-Rho A), which is known to induce formation of actin stress fibers (Ridley and Hall, 1992) , was able to substitute for serum in permitting translocation of v-Src upon shift to the permissive temperature (Fig. 6 e) . Control cells that were microinjected with Lucifer yellow dye and shifted to the permissive temperature and microinjected cells maintained at the restrictive temperature did not show localization of v-Src in focal adhesions (not shown). Although it hasn't been possible for double labeling of cells with vinculin and v-Src (since both antibodies were raised in mice), we observed that the staining pattern of the focal adhesion component vinculin was similar to v-Src. 4 h after refeeding quiescent Swiss 3T3-f29 ceils with serum, vinculin was predominantly present in focal adhesions with some punctate staining also distributed throughout the cell (Fig. 6 3' ). The major difference between the vinculin and v-Src distribution under these conditions is the retention of a substantial amount of v-Src around the nucleus, presumably as a result of its vast overexpression. These observations suggest that v-Src may be transported along actin stress fibers in complexes that are destined to become focal adhesions at the stress fiber termini.
To determine if the serum-induced reformation of actin 
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stress fibers was a prerequisite for v-Src translocation, we provided quiescent Swiss 3T3-f29 cells with serum and shifted to the permissive temperature in the presence of 0.1 Ixg/ml cyotchalasin D, a drug that disrupts the cellular actin cytoskeleton and prevents focal adhesion assembly. The cytoskeleton was severely disrupted in cytochalasin D-treated quiescent Swiss 3T3-f29 cells that had been refed with serum and shifted to 35°C for 4 h, as shown by the lack of stress fibers (phalloidin staining in Fig. 7 a, 1) . In addition, v-Src remained tightly located around the nucleus upon temperature shift (Fig. 7 a, 2) , implying that the cytoskeleton plays an essential role in the transport of v-Src to the cell periphery. Similarly, translocation of v-Src is blocked in quiescent NIH 3T3-f29 ceils upon shift to the permissive temperature (Fig. 7 b, 2) . Consistent with the known requirement for v-Src activity at the cell periphery for mitogenic activity (Catling et al., 1993) , ts LA29 v-Src was unable to activate G0/G1-to S-phase progression in cytochalasin D-treated NIH 3T3-f29 cells upon shift to 35°C (not shown). These data indicate that the actin cytoskeleton plays a crucial role in the translocation, and hence the biological activity, of v-Src.
Translocation of v-src to Focal Adhesions Does Not Require Organized Microtubules
The observations described above do not rule out the possibility that the activated v-Src--containing complexes are associated with structures that align in parallel with the Rho-induced actin stress fibers. This, together with the reported colocalization of c-Src with microtubules (Kaplan et al., 1992) , prompted us to examine whether the microtubular network might be involved in the translocation of v-Src to the cell periphery. Anti--a-tubulin staining of Swiss 3T3-f29 cells displayed a highly cross-linked array of microtubules in the cytoplasm, which was distinct from stress fiber staining and which was unaffected by serum deprivation (Fig. 8 a, for comparison see Figs. 6 b and 8 b). Although the staining patterns of ct-tubulin and phalloidin appeared distinct, the microtubular and actin networks must cross in the cytoplasm and local coalignment may occur. However, treatment of serum-deprived Swiss 3T3-f29 cells with 0.5 ixg/ml of nocodazole, which led to severe disruption of the microtubular network (Fig. 8 b) , did not block the translocation of v-Src to focal adhesions (Fig. 8, c and d) , indicating that the peripheral recruitment of v-Src can occur independently of microtubules.
Recruitment of c-Src to the Cell Periphery also Requires the Actin Cytoskeleton
To determine whether the cytoskeleton was a general mediator of biologically stimulated intracellular transport of Src kinases, we tested whether PDGF, a potent fibroblast mitogen that is known to require the activity of c-Src or its close family members for its effects in NIH 3T3 cells (Twamley-Stein et al., 1993) , was able to induce translocation of c-Src to the cell periphery in a cytoskeleton-dependent manner. We treated quiescent parental NIH 3T3 cells with 5 ng/ml PDGF and examined the subcellular distribution of c-Src using mAb N2-17. In unstimulated cells, c-Src was distributed throughout the cytoplasm (Fig. 9 a) . The strong nuclear staining was also seen when the cells were incubated with FITC-conjugated second antibody alone (data not shown), indicating that it may be nonspecific. In PDGF-treated cells, some c-Src translocated to the cell periphery within 30 min (Fig. 9 b) , where it remained for 60 min (Fig. 9 c) . In some cells, a staining pattern was observed that was consistent with stress fiber alignment at early times after PDGF treatment (e.g. Fig. 9 b, left) . Upon double labeling with phalloidin, it was evident that the peripheral regions to which c-Src was recruited coincided with regions of dense actin staining (not shown), a property that is associated with structures known as membrane ruffles, which are induced by PDGF (Mellstr6m et al., 1988; Ridley and Hall, 1992) . Consistent with a role for the actin cytoskeleton in the translocation of c-Src, cytochalasin D blocked PDGF-induced recruitment of c-Src to the putative membrane ruffles (Fig. 9 d) .
Discussion
In order for v-Src to work as an effective oncoprotein, it must be translocated from its site of synthesis to its site of action at the cell periphery. Early efforts to locate v-Src within Rous sarcoma virus-infected cells produced apparently paradoxical views on its subcellular distribution. Biochemical fractionation, immunofluorescence, and electron microscopy suggested that the majority of v-Src in transformed cells was associated with the plasma membrane (Rohrschneider et al., 1979; Willingham et al., 1979; Courtneidge et al., 1980) . However, there were also reports that v-Src was concentrated in the perinuclear region (Rohrschneider et al., 1979) , associated with the cellular cytoskeleton (Burr et al., 1980) , and located in residual focal adhesions (Rohrschneider, 1979; Nigg et al., 1982; Kreuger et al., 1984; Kellie et al., 1986) . One explanation for these seemingly contradictory claims is provided by our studies using Swiss 3T3 cells that stably express high levels of v-Src protein, but that are resistant to its mitogenic effects as a result of aberrant membrane localization. Immunofluorescence, combined with the resolving power provided by the confocal microscope, has allowed us to propose that the actin cytoskeleton plays an important role in targeting v-Src, and its cellular homolog c-Src, to their sites of action at the cell periphery.
The ts LA29 mutant v-Src differs from the wild-type protein by three amino acid substitutions, one of which is responsible for both temperature-sensitive tyrosine kinase activity and temperature-sensitive localization to the cell periphery (Welham and Wyke, 1988) . Although the ts L A 2 9 v-Src kinase was activated upon shift to permissive temperature in unresponsive serum-deprived Swiss 3T3-f29 cells, it remained perinuclear and, in this location, the kinase activity was not able to induce the downstream signaling consequences of v-Src as judged by activation of MAP kinase and the AP-1 transcription factor. This is consistent with the properties of a myristylation-defective version of ts L A 2 9 v-Src, which is unable to stimulate AP-1 or mitogenesis in CEF (Catling et al., 1993) , and demonstrates conclusively that translocation to the vicinity of its substrates at the cell periphery is an absolute requirement for these biological activities. A clue to the defect in serum-deprived Swiss 3T3 cells that rendered them nonpermissive for activation-dependent v-Src translocation came from knowledge of the extreme phenotype that these cells display in disorganizing the actin cytoskeleton when they are made quiescent by serum-deprivation (Ridley and Hall, 1992; Barry and Critchley, 1994) . Consistent with this, v-Src was translocated to the cell periphery in Swiss 3T3 when the cells were growing in the presence of serum, conditions that restored the actin cytoskeleton and were permissive for v-Src-induced growth in suspension, enhanced growth rate, and morphological transformation. In addition, v-Src is an effective mitogen and transforming agent in other fibroblast cell lines that maintain some organized cytoskeleton when serum deprived.
Serum-induced reformation of the actin cytoskeleton, which is known to be mediated by the small G protein Rho A in Swiss 3T3 cells (Ridley and Hall, 1992) , led to the rapid redistribution of activated v-Src within the cell. At early times after activation, v-Src was present in oval shaped 'structures,' which appeared to align along the newly formed stress fibers. At later times, more v-Src was present in structures that had an elongated shape reminiscent of mature focal adhesions (Barry and Critchley, 1994) at the ends of stress fibers. This pattem of localization suggested that activated v-Src could be recruited into complexes that were destined to become focal adhesions and that these complexes were in turn recruited to the position of functional focal adhesions at the ends of stress fibers, possibly by tracking along the cytoskeleton. The blocking of serum-induced v-Src translocation in Swiss 3T3 cells, and in quiescent NIH 3T3 cells, by the actin cytoskeletondisrupting drug cytochalasin D supports a role for the actin stress fibers in the translocation of v-Src to the cell periphery. Furthermore, the ability of microinjected active Rho A to permit v-Src translocation to focal adhesions indicates a role for the small G protein regulators of the cytoskeleton in actin-dependent protein trafficking.
Although little is known about the mechanics of focal adhesion assembly and the targeting of components to these structures, vinculin staining of Swiss 3T3 cells several hours after serum refeeding displayed a similar distribution in focal adhesions at the cell periphery with some staining in punctate smaller complexes through the cytoplasm. In addition, cytochalasin D-treatment resulted in attenuation of vinculin transport to the focal adhesions as judged by the perinuclear localization of vinculin under these conditions (data not shown). Thus, it is possible that active v-Src-containing complexes that move out from the perinuclear region in response to serum may represent immature focal adhesion complexes. If true, this implies that the actin stress fibers have an important role in the assembly and trafficking of complexes containing focal adhesion components to their sites of action at the stress fiber termini.
In addition to v-Src, we also observed that the cytoskeleton was required for the stimulus-induced translocation of endogenous c-Src from its cytoplasmic location to the cell periphery. In particular, PDGF, a mitogen that requires Src family kinase binding to its activated receptor for activity in NIH 3T3 cells (Twamley-Stein et al., 1993) , stimulated redistribution of c-Src to the plasma membrane, specifically to regions of dense actin staining around the cell periphery. Furthermore, this redistribution was blocked by cytochalasin D, demonstrating that c-Src translocation to the cell periphery is also dependent on the actin cytoskeleton. Since PDGF induces dense regions of actin known as membrane ruffles in Swiss 3T3 cells (Mellstr/Sm et al., 1988; Ridley and Hall, 1992) , a process that involves actin rearrangements mediated by the small G protein Rac , it seems likely that c-Src is being directed to membrane ruffles in NIH 3T3 cells by treatment with PDGF. These data, together with the requirement for the serum-induced, Rho-mediated stress fiber assembly to translocate v-Src to focal adhesions, suggest that the exact peripheral location of Src kinases may be specified by rearrangements of the actin cytoskeleton under the influence of Rho and Rac.
Although little is known about the mechanism or dynamics of v-Src transport from its site of synthesis to its sites of action, molecules that act as binding partners for v-Src before its translocation are candidate mediators of this process. One such signaling intermediate that fulfills this criteria is the p85/pl10 form of phosphatidylinositol (PI) 3-kinase that binds v-Src with kinetics that are indistinguishable from those of activation of the v-Src tyrosine kinase itself in CEF (Haefner et al., 1995) . This, together with the known role of the yeast homologue of the pll0 catalytic subunit of PI 3-kinase, VPS34, in vesicular protein trafficking (Schu et al., 1993) and the recently identified role of PI 3-kinase in the transport of GLUT 4 glucose transporter to the cell membrane (Cheatham et al., 1994; Clarke et al., 1994; Kamohara et al., 1995; Kotani et al., 1995) , suggests that PI 3-kinase is a candidate regulator of v-Src translocation. In addition to PI 3-kinase, other possible regulators of this process include molecules that interact with both v-Src and focal adhesions, such as focal adhesion kinase or paxillin (for review see Schaller and Parsons, 1994) , or v-Src and the cytoskeleton, such as cortactin (Wu and Parsons, 1993) or AFAP (for actin filament-associated pp60 [Src] substrate; Flynn et al., 1993) . The mechanism of actin-dependent Src recruitment to the cell periphery and the potential role of molecules that interact with Src in this process require extensive further experimentation.
In conclusion, we have identified the actin cytoskeleton as an important component of the cellular machinery that translocates Src kinase from its site of synthesis to its sites of action. Furthermore, our observations, when considered with work from Alan Hall's group demonstrating that Rho and Rac are crucial regulators of cytoskeletal assembly (Ridley and Hall, 1992; Nobes and Hall, 1995) , implicate these small G proteins as potential determinants of Src localization mediated by their effects on actin organization. Thus, in addition to its more recognized roles in maintaining cell shape and attachment, in regulating motility, and in basic cell functions, such as cytokinesis, we have demonstrated that the actin cytoskeleton is probably also involved in intracellular transport processes, as has been suggested (Nobes and Hall, 1995) . Examples of protein trafficking along actin tracks have been described (Fath and Burgess, 1994) . More recently, cytoskeletal integrity has also been shown to be required throughout the growth factor-stimulated Gl-phase of the cell cycle in normal cells and to mediate the anchoragedependent expression of cyclin D1 (B6hmer et al., 1996) . In the case of mitogenesis stimulated by the v-Src oncoprotein, however, we have shown that induction of G0/G1-to S-phase progression requires the cytoskeleton for localization at the cell periphery necessary for initiating the mitogenic cascade. Thereafter, v-Src-induced cell cycle progression proceeds independently of cytoskeletal integrity since v-Src activity induces rapid cytoskeletal disorganization (within 1-2 h in CEF) and subsequent transit of Gv Details of the mechanism by which v-Src and other oncoproteins that can induce anchorage-independent growth overcome the normal cytoskeletal-dependent checkpoint in G1 remain to be established.
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